Cargando…
The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya
BACKGROUND AND PURPOSE: To explore the genetic basis and molecular mechanism of native arteriogenesis and therapeutic synangiosis in moyamoya disease (MMD). METHODS: An angiography-based study using patients from a prospective trial of encephaloduroarteriosynangiosis (EDAS) surgery was performed. Th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086844/ https://www.ncbi.nlm.nih.gov/pubmed/35557620 http://dx.doi.org/10.3389/fneur.2022.861184 |
_version_ | 1784704093355245568 |
---|---|
author | Bao, Xiang-Yang Fan, Yan-Na Wang, Qian-Nan Wang, Xiao-Peng Yang, Ri-Miao Zou, Zheng-Xing Zhang, Qian Li, De-Sheng Duan, Lian Yu, Xin-Guang |
author_facet | Bao, Xiang-Yang Fan, Yan-Na Wang, Qian-Nan Wang, Xiao-Peng Yang, Ri-Miao Zou, Zheng-Xing Zhang, Qian Li, De-Sheng Duan, Lian Yu, Xin-Guang |
author_sort | Bao, Xiang-Yang |
collection | PubMed |
description | BACKGROUND AND PURPOSE: To explore the genetic basis and molecular mechanism of native arteriogenesis and therapeutic synangiosis in moyamoya disease (MMD). METHODS: An angiography-based study using patients from a prospective trial of encephaloduroarteriosynangiosis (EDAS) surgery was performed. The spontaneous collaterals grades were evaluated according to the system described by a new grading system. Blood samples were collected from all the recruited patients before EDAS and during the second hospitalization 3 months post-EDAS. We performed Boolean analysis using a combination of specific cell surface markers of CD34(bri)CD133(+)CD45(dim)KDR(+). Genotyping of p.R4810K was also performed. The correlation of age, sex, initial symptoms at diagnosis, collateral grade, Suzuki stages, the RNF213 genotype, time to peak (TTP), and endothelial progenitor cell (EPC) count with good collateral circulation was evaluated. RESULTS: Eighty-five patients with MMD were included in this study. The mutation rate of RNF213 p.R4810K in our study was 25.9% (22/85). The heterozygous mutations were occurred significantly more frequently in the cases that were presented with infarction, worse neurological status, severe posterior cerebral artery (PCA) stenosis, and longer TTP delay. Further, the heterozygous mutations occurred significantly more frequently in the poor collateral stage group. Lower grades were significantly correlated with severe ischemia symptoms, worse neurological status, and a longer TTP delay. The post-operative angiographic findings showed that a good Matsushima grade was correlated with heterozygous mutations, a lower collateral stage, and a longer TTP delay. The CD34(bri)CD133(+)CD45(dim)KDR(+) cell count in patients 3 months post-EDAS was significantly higher as compared to the count before EDAS in the good Matsushima grade group. However, this change was not observed in the poor Matsushima grade group. CONCLUSIONS: These data imply that mutations of RNF213 p.R4810K affect the establishment of spontaneous collateral circulation, and EPCs are involved in the process of formation of new EDAS collaterals. |
format | Online Article Text |
id | pubmed-9086844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90868442022-05-11 The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya Bao, Xiang-Yang Fan, Yan-Na Wang, Qian-Nan Wang, Xiao-Peng Yang, Ri-Miao Zou, Zheng-Xing Zhang, Qian Li, De-Sheng Duan, Lian Yu, Xin-Guang Front Neurol Neurology BACKGROUND AND PURPOSE: To explore the genetic basis and molecular mechanism of native arteriogenesis and therapeutic synangiosis in moyamoya disease (MMD). METHODS: An angiography-based study using patients from a prospective trial of encephaloduroarteriosynangiosis (EDAS) surgery was performed. The spontaneous collaterals grades were evaluated according to the system described by a new grading system. Blood samples were collected from all the recruited patients before EDAS and during the second hospitalization 3 months post-EDAS. We performed Boolean analysis using a combination of specific cell surface markers of CD34(bri)CD133(+)CD45(dim)KDR(+). Genotyping of p.R4810K was also performed. The correlation of age, sex, initial symptoms at diagnosis, collateral grade, Suzuki stages, the RNF213 genotype, time to peak (TTP), and endothelial progenitor cell (EPC) count with good collateral circulation was evaluated. RESULTS: Eighty-five patients with MMD were included in this study. The mutation rate of RNF213 p.R4810K in our study was 25.9% (22/85). The heterozygous mutations were occurred significantly more frequently in the cases that were presented with infarction, worse neurological status, severe posterior cerebral artery (PCA) stenosis, and longer TTP delay. Further, the heterozygous mutations occurred significantly more frequently in the poor collateral stage group. Lower grades were significantly correlated with severe ischemia symptoms, worse neurological status, and a longer TTP delay. The post-operative angiographic findings showed that a good Matsushima grade was correlated with heterozygous mutations, a lower collateral stage, and a longer TTP delay. The CD34(bri)CD133(+)CD45(dim)KDR(+) cell count in patients 3 months post-EDAS was significantly higher as compared to the count before EDAS in the good Matsushima grade group. However, this change was not observed in the poor Matsushima grade group. CONCLUSIONS: These data imply that mutations of RNF213 p.R4810K affect the establishment of spontaneous collateral circulation, and EPCs are involved in the process of formation of new EDAS collaterals. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9086844/ /pubmed/35557620 http://dx.doi.org/10.3389/fneur.2022.861184 Text en Copyright © 2022 Bao, Fan, Wang, Wang, Yang, Zou, Zhang, Li, Duan and Yu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Bao, Xiang-Yang Fan, Yan-Na Wang, Qian-Nan Wang, Xiao-Peng Yang, Ri-Miao Zou, Zheng-Xing Zhang, Qian Li, De-Sheng Duan, Lian Yu, Xin-Guang The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya |
title | The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya |
title_full | The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya |
title_fullStr | The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya |
title_full_unstemmed | The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya |
title_short | The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya |
title_sort | potential mechanism behind native and therapeutic collaterals in moyamoya |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086844/ https://www.ncbi.nlm.nih.gov/pubmed/35557620 http://dx.doi.org/10.3389/fneur.2022.861184 |
work_keys_str_mv | AT baoxiangyang thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT fanyanna thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT wangqiannan thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT wangxiaopeng thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT yangrimiao thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT zouzhengxing thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT zhangqian thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT lidesheng thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT duanlian thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT yuxinguang thepotentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT baoxiangyang potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT fanyanna potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT wangqiannan potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT wangxiaopeng potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT yangrimiao potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT zouzhengxing potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT zhangqian potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT lidesheng potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT duanlian potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya AT yuxinguang potentialmechanismbehindnativeandtherapeuticcollateralsinmoyamoya |